{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:15:32Z","timestamp":1788473732887,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Medical Science and Technology Research Project of Henan Province","award":["[No. 2018020015 to WYG]"],"award-info":[{"award-number":["[No. 2018020015 to WYG]"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["[No. 81370324 to LXC]"],"award-info":[{"award-number":["[No. 81370324 to LXC]"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11010-024-05112-y","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T12:02:19Z","timestamp":1726142539000},"page":"2437-2454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Myeloid-derived suppressor cells alleviate adverse ventricular remodeling after acute myocardial infarction"],"prefix":"10.1007","volume":"480","author":[{"given":"Yan-Ge","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Hang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Xian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"5112_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.664457","volume":"12","author":"I Kologrivova","year":"2021","unstructured":"Kologrivova I, Shtatolkina M, Suslova T, Ryabov V (2021) Cells of the immune system in cardiac remodeling: main players in resolution of inflammation and repair after myocardial infarction. Front Immunol 12:664457. https:\/\/doi.org\/10.3389\/fimmu.2021.664457","journal-title":"Front Immunol"},{"key":"5112_CR2","doi-asserted-by":"publisher","first-page":"1097295","DOI":"10.3389\/fimmu.2023.1097295","volume":"14","author":"W Nian","year":"2023","unstructured":"Nian W, Huang Z, Fu C (2023) Immune cells drive new immunomodulatory therapies for myocardial infarction: from basic to clinical translation. Front Immunol 14:1097295. https:\/\/doi.org\/10.3389\/fimmu.2023.1097295","journal-title":"Front Immunol"},{"key":"5112_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","volume":"18","author":"FK Swirski","year":"2018","unstructured":"Swirski FK, Nahrendorf M (2018) Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat Rev Immunol 18:733\u2013744. https:\/\/doi.org\/10.1038\/s41577-018-0065-8","journal-title":"Nat Rev Immunol"},{"key":"5112_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","volume":"186","author":"SB Ong","year":"2018","unstructured":"Ong SB, Hernandez-Resendiz S, Crespo-Avilan GE, Mukhametshina RT, Kwek XY, Cabrera-Fuentes HA, Hausenloy DJ (2018) Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther 186:73\u201387. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.01.001","journal-title":"Pharmacol Ther"},{"key":"5112_CR5","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.jacc.2014.01.014","volume":"63","author":"IM Seropian","year":"2014","unstructured":"Seropian IM, Toldo S, Van Tassell BW, Abbate A (2014) Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol 63:1593\u20131603. https:\/\/doi.org\/10.1016\/j.jacc.2014.01.014","journal-title":"J Am Coll Cardiol"},{"key":"5112_CR6","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","volume":"67","author":"PC Westman","year":"2016","unstructured":"Westman PC, Lipinski MJ, Luger D, Waksman R, Bonow RO, Wu E, Epstein SE (2016) Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 67:2050\u20132060. https:\/\/doi.org\/10.1016\/j.jacc.2016.01.073","journal-title":"J Am Coll Cardiol"},{"key":"5112_CR7","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/cvr\/cvz050","volume":"115","author":"I Andreadou","year":"2019","unstructured":"Andreadou I, Cabrera-Fuentes HA, Devaux Y, Frangogiannis NG, Frantz S, Guzik T, Liehn EA, Gomes CPC, Schulz R, Hausenloy DJ (2019) Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. Cardiovasc Res 115:1117\u20131130. https:\/\/doi.org\/10.1093\/cvr\/cvz050","journal-title":"Cardiovasc Res"},{"key":"5112_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.990463","volume":"13","author":"H Sui","year":"2022","unstructured":"Sui H, Dongye S, Liu X, Xu X, Wang L, Jin CQ, Yao M, Gong Z, Jiang D, Zhang K, Liu Y, Liu H, Jiang G, Su Y (2022) Immunotherapy of targeting MDSCs in tumor microenvironment. Front Immunol 13:990463. https:\/\/doi.org\/10.3389\/fimmu.2022.990463","journal-title":"Front Immunol"},{"key":"5112_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1586\/1744666X.2015.1052794","volume":"11","author":"H Yang","year":"2015","unstructured":"Yang H, Bi Y, Han F, Lu Y, Wang J, Zhang Z, Liu G (2015) Myeloid-derived suppressor cells in immunity and autoimmunity. Expert Rev Clin Immunol 11:911\u2013919. https:\/\/doi.org\/10.1586\/1744666X.2015.1052794","journal-title":"Expert Rev Clin Immunol"},{"key":"5112_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","volume":"21","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yi M, Niu M, Mei Q, Wu K (2022) Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. Mol Cancer 21:184. https:\/\/doi.org\/10.1186\/s12943-022-01657-y","journal-title":"Mol Cancer"},{"key":"5112_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cytogfr.2022.07.007","volume":"69","author":"W Zhang","year":"2023","unstructured":"Zhang W, Fang X, Gao C, Song C, He Y, Zhou T, Yang X, Shang Y, Xu J (2023) MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets. Cytokine Growth Factor Rev 69:90\u2013103. https:\/\/doi.org\/10.1016\/j.cytogfr.2022.07.007","journal-title":"Cytokine Growth Factor Rev"},{"key":"5112_CR12","doi-asserted-by":"publisher","first-page":"e2250345","DOI":"10.1002\/eji.202250345","volume":"53","author":"M Bekic","year":"2023","unstructured":"Bekic M, Tomic S (2023) Myeloid-derived suppressor cells in the therapy of autoimmune diseases. Eur J Immunol 53:e2250345. https:\/\/doi.org\/10.1002\/eji.202250345","journal-title":"Eur J Immunol"},{"key":"5112_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1189\/jlb.5VMR1116-458RRR","volume":"102","author":"JA Chesney","year":"2017","unstructured":"Chesney JA, Mitchell RA, Yaddanapudi K (2017) Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy. J Leukoc Biol 102:727\u2013740. https:\/\/doi.org\/10.1189\/jlb.5VMR1116-458RRR","journal-title":"J Leukoc Biol"},{"key":"5112_CR14","doi-asserted-by":"publisher","first-page":"1139683","DOI":"10.3389\/fimmu.2023.1139683","volume":"14","author":"Y Ren","year":"2023","unstructured":"Ren Y, Backer H, Muller M, Kienzle A (2023) The role of myeloid derived suppressor cells in musculoskeletal disorders. Front Immunol 14:1139683. https:\/\/doi.org\/10.3389\/fimmu.2023.1139683","journal-title":"Front Immunol"},{"key":"5112_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.117.030811","volume":"138","author":"L Zhou","year":"2018","unstructured":"Zhou L, Miao K, Yin B, Li H, Fan J, Zhu Y, Ba H, Zhang Z, Chen F, Wang J, Zhao C, Li Z, Wang DW (2018) Cardioprotective role of myeloid-derived suppressor cells in heart failure. Circulation 138:181\u2013197. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030811","journal-title":"Circulation"},{"key":"5112_CR16","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1080\/07853890.2022.2084153","volume":"54","author":"Z Yu","year":"2022","unstructured":"Yu Z, Ling Y, Xu Q, Cao Y, Tang S, Fu C (2022) Blocking the A(2B) adenosine receptor alleviates myocardial damage by inhibiting spleen-derived MDSC mobilisation after acute myocardial infarction. Ann Med 54:1616\u20131626. https:\/\/doi.org\/10.1080\/07853890.2022.2084153","journal-title":"Ann Med"},{"key":"5112_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jacc.2011.10.863","volume":"59","author":"YH Liao","year":"2012","unstructured":"Liao YH, Xia N, Zhou SF, Tang TT, Yan XX, Lv BJ, Nie SF, Wang J, Iwakura Y, Xiao H, Yuan J, Jevallee H, Wei F, Shi GP, Cheng X (2012) Interleukin-17A contributes to myocardial ischemia\/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol 59:420\u2013429. https:\/\/doi.org\/10.1016\/j.jacc.2011.10.863","journal-title":"J Am Coll Cardiol"},{"key":"5112_CR18","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.1158\/1078-0432.CCR-05-0883","volume":"11","author":"E Suzuki","year":"2005","unstructured":"Suzuki E, Kapoor V, Jassar AS, Kaiser LR, Albelda SM (2005) Gemcitabine selectively eliminates splenic Gr-1+\/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res 11:6713\u20136721. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0883","journal-title":"Clin Cancer Res"},{"key":"5112_CR19","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.4049\/jimmunol.1200086","volume":"189","author":"H Yi","year":"2012","unstructured":"Yi H, Guo C, Yu X, Zuo D, Wang XY (2012) Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J Immunol 189:4295\u20134304. https:\/\/doi.org\/10.4049\/jimmunol.1200086","journal-title":"J Immunol"},{"key":"5112_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.872","volume":"11","author":"X Xiong","year":"2023","unstructured":"Xiong X, Yu M, Wang D, Wang Y, Cheng L (2023) Th17\/Treg balance is regulated by myeloid-derived suppressor cells in experimental autoimmune myocarditis. Immun Inflamm Dis 11:e872. https:\/\/doi.org\/10.1002\/iid3.872","journal-title":"Immun Inflamm Dis"},{"key":"5112_CR21","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","volume":"373","author":"TT Cung","year":"2015","unstructured":"Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, Bonnefoy-Cudraz E, Guerin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Claeys MJ, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, De Poli F, Morice MC, Ider O, Dubois-Rande JL, Unterseeh T, Le Breton H, Beard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Elmer E, Hansson MJ, Bergerot C, Boussaha I, Jossan C, Derumeaux G, Mewton N, Ovize M (2015) Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med 373:1021\u20131031. https:\/\/doi.org\/10.1056\/NEJMoa1505489","journal-title":"N Engl J Med"},{"key":"5112_CR22","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","volume":"43","author":"S Frantz","year":"2022","unstructured":"Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J (2022) Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J 43:2549\u20132561. https:\/\/doi.org\/10.1093\/eurheartj\/ehac223","journal-title":"Eur Heart J"},{"key":"5112_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis NG (2014) The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 11:255\u2013265. https:\/\/doi.org\/10.1038\/nrcardio.2014.28","journal-title":"Nat Rev Cardiol"},{"key":"5112_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fimmu.2014.00387","volume":"5","author":"S Gantt","year":"2014","unstructured":"Gantt S, Gervassi A, Jaspan H, Horton H (2014) The role of myeloid-derived suppressor cells in immune ontogeny. Front Immunol 5:387. https:\/\/doi.org\/10.3389\/fimmu.2014.00387","journal-title":"Front Immunol"},{"key":"5112_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","volume":"54","author":"S Hegde","year":"2021","unstructured":"Hegde S, Leader AM, Merad M (2021) MDSC: markers, development, states, and unaddressed complexity. Immunity 54:875\u2013884. https:\/\/doi.org\/10.1016\/j.immuni.2021.04.004","journal-title":"Immunity"},{"key":"5112_CR26","doi-asserted-by":"publisher","first-page":"1021634","DOI":"10.3389\/fimmu.2022.1021634","volume":"13","author":"F Zhao","year":"2022","unstructured":"Zhao F, Gong W, Song J, Shen Z, Cui D (2022) The paradoxical role of MDSCs in inflammatory bowel diseases: from bench to bedside. Front Immunol 13:1021634. https:\/\/doi.org\/10.3389\/fimmu.2022.1021634","journal-title":"Front Immunol"},{"key":"5112_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00262-018-2277-y","volume":"68","author":"A Dorhoi","year":"2019","unstructured":"Dorhoi A, Glaria E, Garcia-Tellez T, Nieuwenhuizen NE, Zelinskyy G, Favier B, Singh A, Ehrchen J, Gujer C, Munz C, Saraiva M, Sohrabi Y, Sousa AE, Delputte P, Muller-Trutwin M, Valledor AF (2019) MDSCs in infectious diseases: regulation, roles, and readjustment. Cancer Immunol Immunother 68:673\u2013685. https:\/\/doi.org\/10.1007\/s00262-018-2277-y","journal-title":"Cancer Immunol Immunother"},{"key":"5112_CR28","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/SHK.0000000000001795","volume":"56","author":"SR Sayyadioskoie","year":"2021","unstructured":"Sayyadioskoie SR, Schwacha MG (2021) Myeloid-derived suppressor cells (MDSCs) and the immunoinflammatory response to injury (mini review). Shock 56:658\u2013666. https:\/\/doi.org\/10.1097\/SHK.0000000000001795","journal-title":"Shock"},{"key":"5112_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1177\/17534259231215581","volume":"30","author":"N Bizymi","year":"2024","unstructured":"Bizymi N, Matthaiou AM, Mavroudi I, Batsali A, Papadaki HA (2024) Immunomodulatory actions of myeloid-derived suppressor cells in the context of innate immunity. Innate Immun 30:2\u201310. https:\/\/doi.org\/10.1177\/17534259231215581","journal-title":"Innate Immun"},{"key":"5112_CR30","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3389\/fimmu.2018.02776","volume":"9","author":"S Budhwar","year":"2018","unstructured":"Budhwar S, Verma P, Verma R, Rai S, Singh K (2018) The Yin and Yang of myeloid derived suppressor cells. Front Immunol 9:2776. https:\/\/doi.org\/10.3389\/fimmu.2018.02776","journal-title":"Front Immunol"},{"key":"5112_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020315","author":"M Farahmandnejad","year":"2024","unstructured":"Farahmandnejad M, Mosaddeghi P, Dorvash M, Sakhteman A, Negahdaripour M, Faridi P (2024) Correlation of myeloid-derived suppressor cell expansion with upregulated transposable elements in severe COVID-19 unveiled in single-cell RNA sequencing reanalysis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12020315","journal-title":"Biomedicines"},{"key":"5112_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840620","volume":"13","author":"L Ding","year":"2022","unstructured":"Ding L, Wan M, Wang D, Cao H, Wang H, Gao P (2022) Myeloid-derived suppressor cells in patients with acute pancreatitis with increased inhibitory function. Front Immunol 13:840620. https:\/\/doi.org\/10.3389\/fimmu.2022.840620","journal-title":"Front Immunol"},{"key":"5112_CR33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jcyt.2020.07.008","volume":"22","author":"S Yang","year":"2020","unstructured":"Yang S, Wei Y, Sun R, Lu W, Lv H, Xiao X, Cao Y, Jin X, Zhao M (2020) Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation. Cytotherapy 22:718\u2013733. https:\/\/doi.org\/10.1016\/j.jcyt.2020.07.008","journal-title":"Cytotherapy"},{"key":"5112_CR34","doi-asserted-by":"publisher","first-page":"1275375","DOI":"10.3389\/fimmu.2023.1275375","volume":"14","author":"S Bazargan","year":"2023","unstructured":"Bazargan S, Bunch B, Ojwang AME, Blauvelt J, Landin A, Ali J, Abrahams D, Cox C, Hall AM, Beatty MS, Poch M, Rejniak KA, Pilon-Thomas S (2023) Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer. Front Immunol 14:1275375. https:\/\/doi.org\/10.3389\/fimmu.2023.1275375","journal-title":"Front Immunol"},{"key":"5112_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113006","volume":"42","author":"M von Wulffen","year":"2023","unstructured":"von Wulffen M, Luehrmann V, Robeck S, Russo A, Fischer-Riepe L, van den Bosch M, van Lent P, Loser K, Gabrilovich DI, Hermann S, Roth J, Vogl T (2023) S100A8\/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis. Cell Rep 42:113006. https:\/\/doi.org\/10.1016\/j.celrep.2023.113006","journal-title":"Cell Rep"},{"key":"5112_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095214","author":"A Anzai","year":"2022","unstructured":"Anzai A, Ko S, Fukuda K (2022) Immune and inflammatory networks in myocardial infarction: current research and its potential implications for the clinic. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23095214","journal-title":"Int J Mol Sci"},{"key":"5112_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/bs.acc.2019.07.002","volume":"93","author":"AE Stanciu","year":"2019","unstructured":"Stanciu AE (2019) Cytokines in heart failure. Adv Clin Chem 93:63\u2013113. https:\/\/doi.org\/10.1016\/bs.acc.2019.07.002","journal-title":"Adv Clin Chem"},{"key":"5112_CR38","doi-asserted-by":"publisher","first-page":"7984","DOI":"10.7150\/thno.61423","volume":"11","author":"RA Werner","year":"2021","unstructured":"Werner RA, Hess A, Koenig T, Diekmann J, Derlin T, Melk A, Thackeray JT, Bauersachs J, Bengel FM (2021) Molecular imaging of inflammation crosstalk along the cardio-renal axis following acute myocardial infarction. Theranostics 11:7984\u20137994. https:\/\/doi.org\/10.7150\/thno.61423","journal-title":"Theranostics"},{"key":"5112_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00395-021-00886-4","volume":"116","author":"J Jiao","year":"2021","unstructured":"Jiao J, He S, Wang Y, Lu Y, Gu M, Li D, Tang T, Nie S, Zhang M, Lv B, Li J, Xia N, Cheng X (2021) Regulatory B cells improve ventricular remodeling after myocardial infarction by modulating monocyte migration. Basic Res Cardiol 116:46. https:\/\/doi.org\/10.1007\/s00395-021-00886-4","journal-title":"Basic Res Cardiol"},{"key":"5112_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00395-011-0232-6","volume":"107","author":"TT Tang","year":"2012","unstructured":"Tang TT, Yuan J, Zhu ZF, Zhang WC, Xiao H, Xia N, Yan XX, Nie SF, Liu J, Zhou SF, Li JJ, Yao R, Liao MY, Tu X, Liao YH, Cheng X (2012) Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res Cardiol 107:232. https:\/\/doi.org\/10.1007\/s00395-011-0232-6","journal-title":"Basic Res Cardiol"},{"key":"5112_CR41","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3389\/fimmu.2017.01895","volume":"8","author":"A Dorhoi","year":"2017","unstructured":"Dorhoi A, Du Plessis N (2017) Monocytic myeloid-derived suppressor cells in chronic infections. Front Immunol 8:1895. https:\/\/doi.org\/10.3389\/fimmu.2017.01895","journal-title":"Front Immunol"},{"key":"5112_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25595","volume":"10","author":"F Shan","year":"2024","unstructured":"Shan F, Tang F, Liu Y, Han X, Wu W, Tang Y, Zhan Q, Zhang N (2024) The effect of adoptive transferring myeloid-derived suppressor cells in ventilator-induced lung injury mice. Heliyon 10:e25595. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25595","journal-title":"Heliyon"},{"key":"5112_CR43","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00262-020-02523-w","volume":"69","author":"AA Dar","year":"2020","unstructured":"Dar AA, Patil RS, Pradhan TN, Chaukar DA, D\u2019Cruz AK, Chiplunkar SV (2020) Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma. Cancer Immunol Immunother 69:1071\u20131086. https:\/\/doi.org\/10.1007\/s00262-020-02523-w","journal-title":"Cancer Immunol Immunother"},{"key":"5112_CR44","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1093\/rheumatology\/keaa625","volume":"60","author":"S Chen","year":"2021","unstructured":"Chen S, Guo C, Wang R, Feng Z, Liu Z, Wu L, Zhao D, Zheng S, Chen F, Zhang D, Xu J, Zhu J, Chen X, Li Z, Wise CM, Li J, Wang XY (2021) Monocytic MDSCs skew Th17 cells toward a pro-osteoclastogenic phenotype and potentiate bone erosion in rheumatoid arthritis. Rheumatology (Oxford) 60:2409\u20132420. https:\/\/doi.org\/10.1093\/rheumatology\/keaa625","journal-title":"Rheumatology (Oxford)"},{"key":"5112_CR45","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1038\/s41375-021-01249-7","volume":"35","author":"G Ferrer","year":"2021","unstructured":"Ferrer G, Jung B, Chiu PY, Aslam R, Palacios F, Mazzarello AN, Vergani S, Bagnara D, Chen SS, Yancopoulos S, Xochelli A, Yan XJ, Burger JA, Barrientos JC, Kolitz JE, Allen SL, Stamatopoulos K, Rai KR, Sherry B, Chiorazzi N (2021) Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL. Leukemia 35:3163\u20133175. https:\/\/doi.org\/10.1038\/s41375-021-01249-7","journal-title":"Leukemia"},{"key":"5112_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaut.2017.07.010","volume":"85","author":"A Sica","year":"2017","unstructured":"Sica A, Massarotti M (2017) Myeloid suppressor cells in cancer and autoimmunity. J Autoimmun 85:117\u2013125. https:\/\/doi.org\/10.1016\/j.jaut.2017.07.010","journal-title":"J Autoimmun"},{"key":"5112_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00395-018-0686-x","volume":"113","author":"AJ Mouton","year":"2018","unstructured":"Mouton AJ, DeLeon-Pennell KY, Rivera Gonzalez OJ, Flynn ER, Freeman TC, Saucerman JJ, Garrett MR, Ma Y, Harmancey R, Lindsey ML (2018) Mapping macrophage polarization over the myocardial infarction time continuum. Basic Res Cardiol 113:26. https:\/\/doi.org\/10.1007\/s00395-018-0686-x","journal-title":"Basic Res Cardiol"},{"key":"5112_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112112","volume":"142","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Abak A, Tavakkoli Avval S, Shoorei H, Taheri M, Samadian M (2021) The impact of non-coding RNAs on macrophage polarization. Biomed Pharmacother 142:112112. https:\/\/doi.org\/10.1016\/j.biopha.2021.112112","journal-title":"Biomed Pharmacother"},{"key":"5112_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","volume":"112","author":"M Jung","year":"2017","unstructured":"Jung M, Ma Y, Iyer RP, DeLeon-Pennell KY, Yabluchanskiy A, Garrett MR, Lindsey ML (2017) IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol 112:33. https:\/\/doi.org\/10.1007\/s00395-017-0622-5","journal-title":"Basic Res Cardiol"},{"key":"5112_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008550","volume":"15","author":"L Feng","year":"2022","unstructured":"Feng L, Li G, An J, Liu C, Zhu X, Xu Y, Gao Y, Li J, Liu J, Yan J, Wang Y, Ren J, Yang L, Qi Z (2022) Exercise training protects against heart failure via expansion of myeloid-derived suppressor cells through regulating IL-10\/STAT3\/S100A9 pathway. Circ Heart Fail 15:e008550. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.008550","journal-title":"Circ Heart Fail"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05112-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-05112-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05112-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T19:02:59Z","timestamp":1743706979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-05112-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5112"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-05112-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Life Sciences Ethics Committee of Zhengzhou University (Zhengzhou, China) approved all animal experiments, which were conducted in accordance with the guidelines for Care and Use of Laboratory Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors were informed and consented to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}